Novitium Pharma LLC Discontinued
FDA Approved Drugs

Novitium Pharma LLC Discontinued

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Discontinued
  • Total Records 33
  • Latest Approval Date Jul 29, 2024
  • Data Source FDA
  • First Approval Date Mar 20, 1986
All
206
View
Discontinued
33
View
RX
173
View
Company Overview

Company

Novitium Pharma LLC Discontinued

Country

U.S.A

Website

Visit Website

Email

info@novitiumpharma.com

Social Profiles

Company Snapshot

Novitium Pharma LLC Discontinued

70 Lake Drive East Windsor, NJ 08520

U.S.A

novitiumpharma.com/ info@novitiumpharma.com View on Map
FDA Approved Drug Records ( 33 records )
1991
19 Dec
Discontinued Application: 73542

Drug Name

ATENOLOL

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1991-12-19

73542 / 1

Active Ingredient

ATENOLOL

Application Number

73542

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

1991-12-19

Regulatory Status

Discontinued

1991
19 Dec
Discontinued Application: 73543

Drug Name

ATENOLOL

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1991-12-19

73543 / 1

Active Ingredient

ATENOLOL

Application Number

73543

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

1991-12-19

Regulatory Status

Discontinued

1992
28 Apr
Discontinued Application: 74099

Drug Name

ATENOLOL

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

1992-04-28

74099 / 1

Active Ingredient

ATENOLOL

Application Number

74099

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

1992-04-28

Regulatory Status

Discontinued

1999
05 Mar
Discontinued Application: 75351

Drug Name

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

1999-03-05

75351 / 1

Active Ingredient

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Application Number

75351

Product Number

1

Dosage Form

-

Strength

325MG;50MG;40MG;30MG

Approval Date

1999-03-05

Regulatory Status

Discontinued

1995
23 Jun
Discontinued Application: 74339

Drug Name

CIMETIDINE

Product Number

1

Dosage Form

-

Strength

800MG

Approval Date

1995-06-23

74339 / 1

Active Ingredient

CIMETIDINE

Application Number

74339

Product Number

1

Dosage Form

-

Strength

800MG

Approval Date

1995-06-23

Regulatory Status

Discontinued

1995
23 Jun
Discontinued Application: 74340

Drug Name

CIMETIDINE

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

1995-06-23

74340 / 1

Active Ingredient

CIMETIDINE

Application Number

74340

Product Number

1

Dosage Form

-

Strength

300MG

Approval Date

1995-06-23

Regulatory Status

Discontinued

1995
23 Jun
Discontinued Application: 74340

Drug Name

CIMETIDINE

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

1995-06-23

74340 / 2

Active Ingredient

CIMETIDINE

Application Number

74340

Product Number

2

Dosage Form

-

Strength

400MG

Approval Date

1995-06-23

Regulatory Status

Discontinued

2018
22 Oct
Discontinued Application: 209308

Drug Name

CLOBAZAM

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2018-10-22

209308 / 1

Active Ingredient

CLOBAZAM

Application Number

209308

Product Number

1

Dosage Form

-

Strength

10MG

Approval Date

2018-10-22

Regulatory Status

Discontinued

2018
22 Oct
Discontinued Application: 209308

Drug Name

CLOBAZAM

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2018-10-22

209308 / 2

Active Ingredient

CLOBAZAM

Application Number

209308

Product Number

2

Dosage Form

-

Strength

20MG

Approval Date

2018-10-22

Regulatory Status

Discontinued

2021
19 Oct
Discontinued Application: 209308

Drug Name

CLOBAZAM

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2021-10-19

209308 / 3

Active Ingredient

CLOBAZAM

Application Number

209308

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

2021-10-19

Regulatory Status

Discontinued

2015
14 May
Discontinued Application: 77550

Drug Name

ESCITALOPRAM OXALATE

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2015-05-14

77550 / 1

Active Ingredient

ESCITALOPRAM OXALATE

Application Number

77550

Product Number

1

Dosage Form

-

Strength

EQ 5MG BASE

Approval Date

2015-05-14

Regulatory Status

Discontinued

2015
14 May
Discontinued Application: 77550

Drug Name

ESCITALOPRAM OXALATE

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2015-05-14

77550 / 2

Active Ingredient

ESCITALOPRAM OXALATE

Application Number

77550

Product Number

2

Dosage Form

-

Strength

EQ 10MG BASE

Approval Date

2015-05-14

Regulatory Status

Discontinued

2015
14 May
Discontinued Application: 77550

Drug Name

ESCITALOPRAM OXALATE

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-05-14

77550 / 3

Active Ingredient

ESCITALOPRAM OXALATE

Application Number

77550

Product Number

3

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

2015-05-14

Regulatory Status

Discontinued

1986
20 Mar
Discontinued Application: 70444

Drug Name

FLURAZEPAM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

1986-03-20

70444 / 1

Active Ingredient

FLURAZEPAM HYDROCHLORIDE

Application Number

70444

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

1986-03-20

Regulatory Status

Discontinued

1986
20 Mar
Discontinued Application: 70445

Drug Name

FLURAZEPAM HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

1986-03-20

70445 / 1

Active Ingredient

FLURAZEPAM HYDROCHLORIDE

Application Number

70445

Product Number

1

Dosage Form

-

Strength

30MG

Approval Date

1986-03-20

Regulatory Status

Discontinued

2007
12 Apr
Discontinued Application: 78083

Drug Name

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG;250MG

Approval Date

2007-04-12

78083 / 1

Active Ingredient

GLIPIZIDE; METFORMIN HYDROCHLORIDE

Application Number

78083

Product Number

1

Dosage Form

-

Strength

2.5MG;250MG

Approval Date

2007-04-12

Regulatory Status

Discontinued

2007
12 Apr
Discontinued Application: 78083

Drug Name

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

2.5MG;500MG

Approval Date

2007-04-12

78083 / 2

Active Ingredient

GLIPIZIDE; METFORMIN HYDROCHLORIDE

Application Number

78083

Product Number

2

Dosage Form

-

Strength

2.5MG;500MG

Approval Date

2007-04-12

Regulatory Status

Discontinued

2007
12 Apr
Discontinued Application: 78083

Drug Name

GLIPIZIDE AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

5MG;500MG

Approval Date

2007-04-12

78083 / 3

Active Ingredient

GLIPIZIDE; METFORMIN HYDROCHLORIDE

Application Number

78083

Product Number

3

Dosage Form

-

Strength

5MG;500MG

Approval Date

2007-04-12

Regulatory Status

Discontinued

2019
08 Feb
Discontinued Application: 205990

Drug Name

IMATINIB MESYLATE

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2019-02-08

205990 / 1

Active Ingredient

IMATINIB MESYLATE

Application Number

205990

Product Number

1

Dosage Form

-

Strength

EQ 100MG BASE

Approval Date

2019-02-08

Regulatory Status

Discontinued

2019
08 Feb
Discontinued Application: 205990

Drug Name

IMATINIB MESYLATE

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2019-02-08

205990 / 2

Active Ingredient

IMATINIB MESYLATE

Application Number

205990

Product Number

2

Dosage Form

-

Strength

EQ 400MG BASE

Approval Date

2019-02-08

Regulatory Status

Discontinued

2018
17 Oct
Discontinued Application: 203964

Drug Name

LANSOPRAZOLE

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2018-10-17

203964 / 1

Active Ingredient

LANSOPRAZOLE

Application Number

203964

Product Number

1

Dosage Form

-

Strength

15MG

Approval Date

2018-10-17

Regulatory Status

Discontinued

2018
17 Oct
Discontinued Application: 203964

Drug Name

LANSOPRAZOLE

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2018-10-17

203964 / 2

Active Ingredient

LANSOPRAZOLE

Application Number

203964

Product Number

2

Dosage Form

-

Strength

30MG

Approval Date

2018-10-17

Regulatory Status

Discontinued

2013
12 Nov
Discontinued Application: 201466

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2013-11-12

201466 / 1

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

201466

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2013-11-12

Regulatory Status

Discontinued

2013
12 Nov
Discontinued Application: 201466

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG/5ML

Approval Date

2013-11-12

201466 / 2

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

201466

Product Number

2

Dosage Form

-

Strength

10MG/5ML

Approval Date

2013-11-12

Regulatory Status

Discontinued

2000
08 Mar
Discontinued Application: 75434

Drug Name

NALTREXONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2000-03-08

75434 / 1

Active Ingredient

NALTREXONE HYDROCHLORIDE

Application Number

75434

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

2000-03-08

Regulatory Status

Discontinued

2018
23 Nov
Discontinued Application: 210681

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-11-23

210681 / 1

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

210681

Product Number

1

Dosage Form

-

Strength

EQ 150MG BASE

Approval Date

2018-11-23

Regulatory Status

Discontinued

2018
23 Nov
Discontinued Application: 210681

Drug Name

RANITIDINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-11-23

210681 / 2

Active Ingredient

RANITIDINE HYDROCHLORIDE

Application Number

210681

Product Number

2

Dosage Form

-

Strength

EQ 300MG BASE

Approval Date

2018-11-23

Regulatory Status

Discontinued

1997
26 Nov
Discontinued Application: 74866

Drug Name

SELEGILINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1997-11-26

74866 / 1

Active Ingredient

SELEGILINE HYDROCHLORIDE

Application Number

74866

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

1997-11-26

Regulatory Status

Discontinued

2000
01 May
Discontinued Application: 75237

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2000-05-01

75237 / 1

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75237

Product Number

1

Dosage Form

-

Strength

80MG

Approval Date

2000-05-01

Regulatory Status

Discontinued

2000
01 May
Discontinued Application: 75237

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2000-05-01

75237 / 2

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75237

Product Number

2

Dosage Form

-

Strength

120MG

Approval Date

2000-05-01

Regulatory Status

Discontinued

2000
01 May
Discontinued Application: 75237

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2000-05-01

75237 / 3

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75237

Product Number

3

Dosage Form

-

Strength

160MG

Approval Date

2000-05-01

Regulatory Status

Discontinued

2000
01 May
Discontinued Application: 75237

Drug Name

SOTALOL HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

240MG

Approval Date

2000-05-01

75237 / 4

Active Ingredient

SOTALOL HYDROCHLORIDE

Application Number

75237

Product Number

4

Dosage Form

-

Strength

240MG

Approval Date

2000-05-01

Regulatory Status

Discontinued

2024
29 Jul
Discontinued Application: 218139

Drug Name

TEZRULY

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML

Approval Date

2024-07-29

218139 / 1

Active Ingredient

TERAZOSIN HYDROCHLORIDE

Application Number

218139

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE/ML

Approval Date

2024-07-29

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    5 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    206 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
33 total
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ATENOLOL

Application Number

73542

Product Number

1

Active Ingredient

ATENOLOL

Dosage Form

-

Strength

50MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit